Bulandres, Marites .

HRN: 20-88-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
CEFUROXIME 500MG (TAB)
02/19/2024
02/26/2024
ORAL
500mg
BID
S/P Pelvic Laparotomy
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: